Nidhi Anand
Overview
Explore the profile of Nidhi Anand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dixit S, Sharma P, Gupta A, Anand N, Dhanda M
Diagn Cytopathol
. 2024 Dec;
53(4):E56-E60.
PMID: 39721984
Introduction: Thyroid lesions are one of the most common diseases observed in clinical practice in the North India. These diseases have distinct cytological morphology and thus FNAC is done frequently....
2.
Singh N, Thakur K, Moidu S, Anand N
Radiol Case Rep
. 2024 Oct;
19(12):6152-6156.
PMID: 39376949
Pheochromocytoma is a rare neuroendocrine tumor arising from adrenal medulla. Patients usually show classic triad of headache, palpitations and diaphoresis along with persistent or paroxysmal hypertension. Majority of the tumors...
3.
Anand N, Srivastava P, Husain N, Agarwal D, Gupta A, Pradhan R
Cureus
. 2024 Sep;
16(8):e67004.
PMID: 39286684
Introduction Immune checkpoint inhibitors (ICIs) targeting cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) and programmed death-ligand 1 (PD-L1) have revolutionised treatment and improved outcomes in various malignancies. We aimed to evaluate CTLA-4 and...
4.
Anand N, Srivastava P, Agrawal A, Gupta N, Das A, Husain N
Int Arch Otorhinolaryngol
. 2024 Apr;
28(2):e240-e246.
PMID: 38618587
Many patients suffered from rhino-orbital-cerebral mucormycosis during the coronavirus disease 2019 (COVID-19) pandemic in India. Diabetes is a known risk factor of COVID-19 infection and mucormycosis. The present study was...
5.
Shukla S, Anand N, Pandey R, Hadi R, Husain N
J Microsc Ultrastruct
. 2024 Jan;
11(4):220-224.
PMID: 38213647
Background: Immunotherapy is now a vital target therapy in the advanced cases of lung adenocarcinoma. The outstanding result of therapies with medications that inhibit the interaction of programmed death ligand...
6.
Marak J, Chauhan A, Anand N, Khurana R
BMJ Case Rep
. 2023 Sep;
16(9).
PMID: 37758655
Small cell neuroendocrine carcinoma of nasopharynx is extremely rare and displays aggressive nature with a poor prognosis. Neuroendocrine tumours rarely arise from the head and neck region and pose a...
7.
Anand N, Sachan R, Dhanda M, Husain N
BMJ Case Rep
. 2023 Sep;
16(9).
PMID: 37730422
Primary hyperparathyroidism caused by parathyroid carcinoma is extremely rare. Clinically, it is very challenging to differentiate between parathyroid carcinoma and adenoma. The correct diagnosis is made based on the histopathology...
8.
Sachan R, Gupta A, Awasthi P, Singh P, Anand N, Chandra S, et al.
J Am Soc Cytopathol
. 2023 May;
12(5):351-361.
PMID: 37244848
Introduction: Serous fluid cytology is a cost-effective procedure that can help in the diagnosis, staging, and origin of the malignancy. Recently introduced International System for Reporting Serous Fluid Cytology (ISRSFC)...
9.
Kumari S, Mishra S, Anand N, Hadi R, Rastogi M, Husain N
Pathol Res Pract
. 2023 May;
246:154489.
PMID: 37150134
Circulating free DNA (cfDNA) is in use for the non-invasive diagnosis of tumors. Methylation of tumor suppressor genes (TSGs) is an early event in carcinogenesis and may serve as tumor...
10.
Anand N, Husain N, Varshney R, Malhotra K, Kaif M
J Carcinog
. 2021 Nov;
20:20.
PMID: 34729052
Background: Diffuse gliomas in the adult population are the most common primary central nervous system (CNS) tumors. The World Health Organization incorporated isocitrate dehydrogenase (IDH) mutations and 1p/19q co-deletion with...